Get the Stockscreener App
2.50
4.58%
-0.12
After Hours:
2.54
0.04
+1.60%
Alzamend Neuro Inc stock is traded at $2.50, with a volume of 155.32K.
It is down -4.58% in the last 24 hours and up +5.26% over the past month.
Alzamend Neuro Inc is an early clinical-stage biopharmaceutical company. It is focused on developing novel products for the treatment of neurodegenerative diseases and psychiatric disorders, including Alzheimer's. Its mission is to develop and market safe and effective treatments. The company's pipeline consists of two novel therapeutic drug candidates, AL001 - a patented ionic cocrystal technology delivering lithium via a therapeutic combination of lithium, proline and salicylate, and AL002 - a patented method using a mutant-peptide sensitized cell as a cell-based therapeutic vaccine that seeks to restore the ability of a patient's immunological system to combat Alzheimer's.
See More
Previous Close:
$2.62
Open:
$2.57
24h Volume:
155.32K
Relative Volume:
0.92
Market Cap:
$7.85M
Revenue:
-
Net Income/Loss:
$-5.85M
P/E Ratio:
-0.3738
EPS:
-6.6877
Net Cash Flow:
$-8.00M
1W Performance:
+6.38%
1M Performance:
+5.26%
6M Performance:
-68.96%
1Y Performance:
-83.47%
1-Day Range:
$2.45
$2.6199
1-Week Range:
$2.30
$2.64
52-Week Range:
$2.06
$17.10
Alzamend Neuro Inc Stock (ALZN) Company Profile
Name
Alzamend Neuro Inc
Sector
Industry
Phone
844-722-6333
Address
3500 LENOX RD. NE, ATLANTA
Compare ALZN with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ALZN
Alzamend Neuro Inc
|
2.50 | 8.23M | 0 | -5.85M | -8.00M | -6.6877 |
|
VRTX
Vertex Pharmaceuticals Inc
|
387.15 | 100.34B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
585.50 | 60.95B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
451.73 | 60.46B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
734.35 | 46.04B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
332.20 | 36.02B | 3.81B | -644.79M | -669.77M | -6.24 |
Alzamend Neuro Inc Stock (ALZN) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Oct-01-21 | Initiated | Ascendiant Capital Markets | Buy |
Alzamend Neuro Inc Stock (ALZN) Latest News
Can volume confirm reversal in Alzamend Neuro Inc.Weekly Gains Summary & Scalable Portfolio Growth Methods - newser.com
Using fundamentals and technicals on Alzamend Neuro Inc.Sell Signal & AI Enhanced Trade Execution Alerts - newser.com
Is Alzamend Neuro Inc. stock reversal real or fakePortfolio Growth Summary & Momentum Based Trading Signals - newser.com
Real time pattern detection on Alzamend Neuro Inc. stockIPO Watch & Target Return Focused Stock Picks - newser.com
Can Alzamend Neuro Inc reach all time highs this yearEarnings Trend Report & Precise Swing Trade Alerts - خودرو بانک
Update Report: Whats the fair value of Alzamend Neuro Inc stockShare Buyback & Growth Focused Investment Plans - خودرو بانک
Market Overview: Will Alzamend Neuro Inc stock benefit from M A2025 Price Action Summary & Daily Stock Trend Watchlist - خودرو بانک
Risk adjusted return profile for Alzamend Neuro Inc. analyzedInflation Watch & Weekly Momentum Stock Picks - newser.com
Levels Update: Does Alzamend Neuro Inc stock reflect fundamentalsJuly 2025 Rallies & Expert Approved Trade Ideas - خودرو بانک
Highs Report: Does LSCC have high return on assetsShort Setup & Weekly High Potential Stock Alerts - خودرو بانک
How sentiment analysis helps forecast Alzamend Neuro Inc.2025 Historical Comparison & Entry Point Strategy Guides - newser.com
Is Alzamend Neuro Inc. stock bottoming outJuly 2025 Institutional & Growth Focused Entry Reports - newser.com
Aug Reactions: Is Alzamend Neuro Inc stock showing strong momentum2025 Market Outlook & Free Safe Capital Growth Stock Tips - خودرو بانک
Aug Selloffs: What is Alzamend Neuro Inc.’s TAM (Total Addressable Market)2025 Macro Impact & Fast Exit Strategy with Risk Control - خودرو بانک
Retail Trends: Is Alzamend Neuro Inc undervalued by DCF analysisWeekly Stock Report & Risk Adjusted Buy/Sell Alerts - خودرو بانک
Detecting price anomalies in Alzamend Neuro Inc. with AIEarnings Growth Report & Pattern Based Trade Signal System - newser.com
Published on: 2025-09-15 11:08:17 - newser.com
Guidance Update: Can Alzamend Neuro Inc reach all time highs this yearM&A Rumor & High Win Rate Trade Alerts - خودرو بانک
Alzamend Neuro Inc. stock retracement – recovery analysisTrend Reversal & Reliable Entry Point Alerts - newser.com
Sector ETF performance correlation with Alzamend Neuro Inc.Breakout Watch & Free Growth Oriented Trading Recommendations - newser.com
Will Alzamend Neuro Inc. price bounce be sustainableQuarterly Growth Report & Accurate Trade Setup Notifications - newser.com
Custom strategy builders for tracking Alzamend Neuro Inc.Dollar Strength & Daily Profit Focused Screening - newser.com
What momentum shifts mean for Alzamend Neuro Inc.July 2025 Update & Free Real-Time Market Sentiment Alerts - newser.com
Reversal indicators forming on Alzamend Neuro Inc. stockWeekly Profit Recap & Daily Volume Surge Signals - newser.com
Is Alzamend Neuro Inc. meeting your algorithmic filter criteria2025 Major Catalysts & Smart Money Movement Alerts - Newser
Real time breakdown of Alzamend Neuro Inc. stock performanceWeekly Stock Summary & Daily Stock Trend Reports - Newser
What does recent volatility data suggest for Alzamend Neuro Inc.July 2025 PreEarnings & Real-Time Volume Surge Alerts - Newser
How to use a screener to detect Alzamend Neuro Inc. breakoutsNew Guidance & Verified Momentum Watchlists - Newser
Technical signs of recovery in Alzamend Neuro Inc.Risk Management & Weekly High Conviction Ideas - Newser
Will breakout in Alzamend Neuro Inc. lead to full recoveryJuly 2025 Technicals & Stepwise Entry/Exit Trade Alerts - Newser
Can swing trading help recover from Alzamend Neuro Inc. lossesDividend Hike & Real-Time Stock Movement Alerts - Newser
Key metrics from Alzamend Neuro Inc.’s quarterly dataTrade Entry Report & High Conviction Trade Alerts - Newser
Is this a good reentry point in Alzamend Neuro Inc.July 2025 Trends & Free Low Drawdown Momentum Trade Ideas - Newser
Multi factor analysis applied to Alzamend Neuro Inc.New Guidance & Verified Momentum Stock Watchlist - Newser
Will a bounce in Alzamend Neuro Inc. offer an exit2025 Investor Takeaways & AI Powered Market Entry Ideas - Newser
Will Alzamend Neuro Inc. bounce back from current supportMarket Growth Review & Growth-Oriented Investment Plans - Newser
Using flow based indicators on Alzamend Neuro Inc.Market Movers & Proven Capital Preservation Methods - Newser
Developing predictive dashboards with Alzamend Neuro Inc. dataBuy Signal & Weekly Stock Performance Updates - Newser
Alzamend Neuro Inc Stock (ALZN) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.62%
0.57%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):